1. Home
  2. LSTA vs COSM Comparison

LSTA vs COSM Comparison

Compare LSTA & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • COSM
  • Stock Information
  • Founded
  • LSTA 1980
  • COSM 2009
  • Country
  • LSTA United States
  • COSM United States
  • Employees
  • LSTA N/A
  • COSM N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • COSM Other Pharmaceuticals
  • Sector
  • LSTA Health Care
  • COSM Health Care
  • Exchange
  • LSTA Nasdaq
  • COSM Nasdaq
  • Market Cap
  • LSTA 20.0M
  • COSM 10.1M
  • IPO Year
  • LSTA N/A
  • COSM 2013
  • Fundamental
  • Price
  • LSTA $2.07
  • COSM $0.44
  • Analyst Decision
  • LSTA Strong Buy
  • COSM
  • Analyst Count
  • LSTA 1
  • COSM 0
  • Target Price
  • LSTA $15.00
  • COSM N/A
  • AVG Volume (30 Days)
  • LSTA 9.1K
  • COSM 113.1K
  • Earning Date
  • LSTA 05-08-2025
  • COSM 11-14-2024
  • Dividend Yield
  • LSTA N/A
  • COSM N/A
  • EPS Growth
  • LSTA N/A
  • COSM N/A
  • EPS
  • LSTA N/A
  • COSM N/A
  • Revenue
  • LSTA $1,000,000.00
  • COSM $56,042,109.00
  • Revenue This Year
  • LSTA N/A
  • COSM $4.53
  • Revenue Next Year
  • LSTA N/A
  • COSM $25.00
  • P/E Ratio
  • LSTA N/A
  • COSM N/A
  • Revenue Growth
  • LSTA N/A
  • COSM 13.02
  • 52 Week Low
  • LSTA $2.05
  • COSM $0.35
  • 52 Week High
  • LSTA $4.20
  • COSM $1.58
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 34.86
  • COSM 35.57
  • Support Level
  • LSTA $2.31
  • COSM $0.35
  • Resistance Level
  • LSTA $2.46
  • COSM $0.52
  • Average True Range (ATR)
  • LSTA 0.15
  • COSM 0.04
  • MACD
  • LSTA -0.01
  • COSM -0.00
  • Stochastic Oscillator
  • LSTA 0.00
  • COSM 49.71

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Share on Social Networks: